(VIANEWS) – Good morning! Another day of trading is almost starting and here’s today’s list of stocks that have had significant trading activity in the US premarket session.
The three biggest winners today are Alibaba, SmileDirectClub, and MicroVision.
| Rank | Financial Asset | Price | Premarket Change |
Updated (EST) |
|---|---|---|---|---|
| 1 | Alibaba (BABA) | 100.96 | 6.52% | 2023-02-23 07:25:22 |
| 2 | SmileDirectClub (SDC) | 0.54 | 5.1% | 2023-02-23 07:19:10 |
| 3 | MicroVision (MVIS) | 2.77 | 4.92% | 2023-02-23 07:29:17 |
| 4 | Tattooed Chef (TTCF) | 1.46 | 2.82% | 2023-02-23 07:23:02 |
| 5 | Lloyds Banking Group (LYG) | 2.49 | 2.05% | 2023-02-23 07:15:59 |
| 6 | United Microelectronics (UMC) | 8.16 | 1.87% | 2023-02-23 07:20:51 |
| 7 | FuboTV (FUBO) | 2.34 | 1.74% | 2023-02-23 07:22:20 |
| 8 | Virgin Galactic (SPCE) | 5.89 | 1.73% | 2023-02-23 07:22:04 |
| 9 | Intel (INTC) | 25.90 | 1.69% | 2023-02-23 07:28:13 |
| 10 | Fortinet (FTNT) | 61.21 | 1.66% | 2023-02-23 07:21:49 |
The three biggest losers today are ImmunoGen, Banco Bradesco, and GlaxoSmithKline.
| Rank | Financial Asset | Price | Premarket Change |
Updated (EST) |
|---|---|---|---|---|
| 1 | ImmunoGen (IMGN) | 3.83 | -3.04% | 2023-02-23 04:28:10 |
| 2 | Banco Bradesco (BBDO) | 2.30 | -1.29% | 2023-02-23 04:10:32 |
| 3 | GlaxoSmithKline (GSK) | 35.15 | -0.71% | 2023-02-23 07:29:34 |
| 4 | Canopy Growth (CGC) | 2.38 | -0.42% | 2023-02-23 06:15:15 |
| 5 | United States Steel (X) | 28.27 | -0.42% | 2023-02-23 07:21:44 |
| 6 | Sabre Corporation (SABR) | 5.08 | -0.39% | 2023-02-23 07:30:26 |
| 7 | Horizon Therapeutics (HZNP) | 110.37 | -0.35% | 2023-02-23 04:12:37 |
| 8 | U.S. Gold Corp (USAU) | 4.14 | -0.24% | 2023-02-23 04:19:49 |
| 9 | Sempra Energy (SRE) | 155.00 | -0.1% | 2023-02-23 04:19:36 |
| 10 | Rollins (ROL) | 35.42 | -0.03% | 2023-02-23 04:18:53 |
Premarket Winners today
1. Alibaba (BABA) – Premarket: 6.52%
Alibaba Group Holding Limited, through its subsidiaries, provides technology infrastructure and marketing reach to help merchants, brands, retailers, and other businesses to engage with their users and customers in the People's Republic of China and internationally. The company operates through seven segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others. It operates Taobao Marketplace, a social commerce platform; Tmall, a third-party online and mobile commerce platform for brands and retailers; Alimama, a monetization platform; 1688.com and Alibaba.com, which are online wholesale marketplaces; AliExpress, a retail marketplace; Lazada, Trendyol, and Daraz that are e-commerce platforms; Freshippo, a self-operated retail chain; and Tmall Global, an import e-commerce platform. The company also operates Taoxianda, an online-offline integration service for FMCG brands and third-party grocery retail partners; Cainiao Network logistic services platform; Ele.me, an on-demand delivery and local services platform; Koubei, a restaurant and local services guide platform; and Fliggy, an online travel platform. In addition, it offers pay-for-performance, in-feed, and display marketing services; and Taobao Ad Network and Exchange, a real-time online bidding marketing exchange. Further, the company provides elastic computing, storage, network, security, database and big data, and IoT services. Additionally, it operates Youku, an online video platform; Alibaba Pictures and other content platforms that provide online videos, films, live events, news feeds, literature, music, and others; Amap, a mobile digital map, navigation, and real-time traffic information app; DingTalk, a business efficiency mobile app; and Tmall Genie smart speaker. The company was incorporated in 1999 and is based in Hangzhou, the People's Republic of China.
NYSE ended the session with Alibaba falling 0.34% to $94.78 on Thursday, after three consecutive sessions in a row of losses. NYSE slid 0.27% to $15,530.83, after five consecutive sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.
Earnings Per Share
As for profitability, Alibaba has a trailing twelve months EPS of $8.95.
PE Ratio
Alibaba has a trailing twelve months price to earnings ratio of 10.59. Meaning, the purchaser of the share is investing $10.59 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -0.12%.
More news about Alibaba.
2. SmileDirectClub (SDC) – Premarket: 5.1%
SmileDirectClub, Inc., an oral care company, offers clear aligner therapy treatment. The company manages the end-to-end process, which include marketing, aligner manufacturing, fulfillment, treatment by a doctor, and monitoring through completion of their treatment with a network of approximately 250 licensed orthodontists and general dentists through its teledentistry platform, SmileCheck in the United States, Puerto Rico, Canada, Australia, the United Kingdom, New Zealand, Ireland, Hong Kong, Germany, Singapore, France, Spain, and Austria. It also offers aligners, impression and whitening kits, whitening gels, and retainers; and toothbrushes, toothpastes, water flossers, SmileSpa, and various ancillary oral care products. The company was founded in 2014 and is headquartered in Nashville, Tennessee.
NASDAQ ended the session with SmileDirectClub sliding 2.92% to $0.51 on Thursday, after five successive sessions in a row of losses. NASDAQ rose 0.13% to $11,507.07, following the last session’s upward trend on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, SmileDirectClub has a trailing twelve months EPS of $-2.334.
More news about SmileDirectClub.
3. MicroVision (MVIS) – Premarket: 4.92%
MicroVision, Inc. develops lidar sensors used in automotive safety and autonomous driving applications. Its laser beam scanning technology is based on micro-electrical mechanical systems, laser diodes, opto-mechanics, electronics, algorithms, and software. The company also develops micro-display concepts and designs for head-mounted augmented reality (AR) headsets, as well as 1440i MEMS module that can support AR headsets; Interactive Display modules used in smart speakers and other devices; and Consumer Lidar used in smart home systems. In addition, it provides PicoP, a scanning technology that creates full color, high-contrast, and uniform image over the entire field-of-view from a small and thin module. Further, the company develops 1st generation long range lidar. The company sells its products primarily to original equipment manufacturers and original design manufacturers. MicroVision, Inc. was founded in 1993 and is headquartered in Redmond, Washington.
NASDAQ ended the session with MicroVision jumping 0.19% to $2.64 on Thursday while NASDAQ jumped 0.13% to $11,507.07.
Earnings Per Share
As for profitability, MicroVision has a trailing twelve months EPS of $-0.102.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -50.24%.
More news about MicroVision.
4. Tattooed Chef (TTCF) – Premarket: 2.82%
Tattooed Chef, Inc., a plant-based food company, produces and sells a portfolio of frozen foods. It supplies plant-based products to retailers in the United States. The company offers ready-to-cook bowls, zucchini spirals, riced cauliflower, acai and smoothie bowls, cauliflower crust pizza, and plant-based burgers. Its products are available in private label and Tattooed Chef brand name in the frozen food section of retail food stores. As of December 31, 2021, it operated approximately 14,000 retail outlets. Tattooed Chef, Inc. is headquartered in Paramount, California.
NASDAQ ended the session with Tattooed Chef rising 5.6% to $1.42 on Thursday, after two sequential sessions in a row of gains. NASDAQ rose 0.13% to $11,507.07, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, Tattooed Chef has a trailing twelve months EPS of $-0.069.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -38.9%.
Sales Growth
Tattooed Chef’s sales growth is 26.4% for the current quarter and 15.4% for the next.
Yearly Top and Bottom Value
Tattooed Chef’s stock is valued at $1.42 at 07:34 EST, way below its 52-week low of $5.84.
Volume
Today’s last reported volume for Tattooed Chef is 478180 which is 62.05% below its average volume of 1260230.
More news about Tattooed Chef.
5. Lloyds Banking Group (LYG) – Premarket: 2.05%
Lloyds Banking Group plc, together with its subsidiaries, provides a range of banking and financial services in the United Kingdom. It operates through three segments: Retail; Commercial Banking; and Insurance and Wealth. The Retail segment offers a range of financial service products, including current accounts, savings, mortgages, motor finance, unsecured loans, leasing solutions, and credit cards to personal and small business customers. The Commercial Banking segment provides lending, transactional banking, working capital management, risk management, debt financing, and debt capital market services to small and medium-sized entities, corporates, and financial institutions. The Insurance and Wealth segment offers insurance, investment and wealth management products and services. It also provides digital banking services. The company offers its products and services under the Lloyds Bank, Halifax, Bank of Scotland, and Scottish Widows brands. Lloyds Banking Group plc was founded in 1695 and is based in London, the United Kingdom.
NYSE ended the session with Lloyds Banking Group jumping 1.88% to $2.44 on Thursday while NYSE slid 0.27% to $15,530.83.
Earnings Per Share
As for profitability, Lloyds Banking Group has a trailing twelve months EPS of $0.0003.
PE Ratio
Lloyds Banking Group has a trailing twelve months price to earnings ratio of 7378.79. Meaning, the purchaser of the share is investing $7378.79 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9%.
Volatility
Lloyds Banking Group’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.26%, a positive 0.60%, and a positive 1.38%.
Lloyds Banking Group’s highest amplitude of average volatility was 0.52% (last week), 1.23% (last month), and 1.38% (last quarter).
Revenue Growth
Year-on-year quarterly revenue growth declined by 10.8%, now sitting on 16.2B for the twelve trailing months.
More news about Lloyds Banking Group.
6. United Microelectronics (UMC) – Premarket: 1.87%
United Microelectronics Corporation operates as a semiconductor wafer foundry in Taiwan, Singapore, China, Hong Kong, Japan, the United States, Europe, and internationally. The company provides circuit design, mask tooling, wafer fabrication, and assembly and testing services. It serves fabless design companies and integrated device manufacturers. United Microelectronics Corporation was incorporated in 1980 and is headquartered in Hsinchu City, Taiwan.
NYSE ended the session with United Microelectronics sliding 0.31% to $8.01 on Thursday while NYSE slid 0.27% to $15,530.83.
Earnings Per Share
As for profitability, United Microelectronics has a trailing twelve months EPS of $0.55.
PE Ratio
United Microelectronics has a trailing twelve months price to earnings ratio of 14.69. Meaning, the purchaser of the share is investing $14.69 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.62%.
More news about United Microelectronics.
7. FuboTV (FUBO) – Premarket: 1.74%
fuboTV Inc. operates a live TV streaming platform for live sports, news, and entertainment content in the United States and internationally. Its fuboTV platform allows customers to access content through streaming devices, as well as on SmartTVs, computers, mobile phones, and tablets. The company is headquartered in New York, New York.
NYSE ended the session with FuboTV rising 1.32% to $2.30 on Thursday while NYSE fell 0.27% to $15,530.83.
Earnings Per Share
As for profitability, FuboTV has a trailing twelve months EPS of $-3.735.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -66.53%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, FuboTV’s stock is considered to be overbought (>=80).
Revenue Growth
Year-on-year quarterly revenue growth grew by 102.2%, now sitting on 760.65M for the twelve trailing months.
Volatility
FuboTV’s last week, last month’s, and last quarter’s current intraday variation average was a negative 7.83%, a negative 0.26%, and a positive 4.65%.
FuboTV’s highest amplitude of average volatility was 7.83% (last week), 5.63% (last month), and 4.65% (last quarter).
Growth Estimates Quarters
The company’s growth estimates for the present quarter is a negative 18.6% and positive 5.9% for the next.
More news about FuboTV.
8. Virgin Galactic (SPCE) – Premarket: 1.73%
Virgin Galactic Holdings, Inc. focuses on the development, manufacture, and operation of spaceships and related technologies for conducting commercial human spaceflight and flying commercial research and development payloads into space. It is also involved in the ground and flight testing, and post-flight maintenance of its spaceflight system vehicles. The company serves private individuals, researchers, and government agencies. Virgin Galactic Holdings, Inc. was founded in 2017 is headquartered in Las Cruces, New Mexico. Virgin Galactic Holdings, Inc. was a former subsidiary of Virgin Orbit Holdings, Inc.
NYSE ended the session with Virgin Galactic rising 0.74% to $5.79 on Thursday, after two consecutive sessions in a row of gains. NYSE fell 0.27% to $15,530.83, after five successive sessions in a row of losses, on what was a somewhat down trend trading session today.
Earnings Per Share
As for profitability, Virgin Galactic has a trailing twelve months EPS of $-1.55.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -53.97%.
Moving Average
Virgin Galactic’s worth is way below its 50-day moving average of $6.50 and way below its 200-day moving average of $8.30.
Yearly Top and Bottom Value
Virgin Galactic’s stock is valued at $5.79 at 07:34 EST, way below its 52-week high of $26.50 and way higher than its 52-week low of $4.76.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is 12.8% and a drop 12.5% for the next.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Virgin Galactic’s stock is considered to be overbought (>=80).
More news about Virgin Galactic.
9. Intel (INTC) – Premarket: 1.69%
Intel Corporation designs, develops, manufactures, markets, and sells computing and related products worldwide. It operates through Client Computing Group, Data Center and AI, Network and Edge, Mobileye, Accelerated Computing Systems and Graphics, Intel Foundry Services, and Other segments. The company offers platform products, such as central processing units and chipsets, and system-on-chip and multichip packages; and accelerators, boards and systems, connectivity products, and memory and storage products. It also provides high-performance compute solutions for targeted verticals and embedded applications for retail, industrial, and healthcare markets; and solutions for assisted and autonomous driving comprising compute platforms, computer vision and machine learning-based sensing, mapping and localization, driving policy, and active sensors. In addition, the company offers workload-optimized platforms and related products for cloud service providers, enterprise and government, and communications service providers. It serves original equipment manufacturers, original design manufacturers, cloud service providers, and other equipment manufacturers. The company was incorporated in 1968 and is headquartered in Santa Clara, California.
NASDAQ ended the session with Intel dropping 2.28% to $25.47 on Thursday, after four consecutive sessions in a row of losses. NASDAQ rose 0.13% to $11,507.07, following the last session’s upward trend on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, Intel has a trailing twelve months EPS of $4.46.
PE Ratio
Intel has a trailing twelve months price to earnings ratio of 5.71. Meaning, the purchaser of the share is investing $5.71 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.07%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Intel’s stock is considered to be overbought (>=80).
Moving Average
Intel’s value is under its 50-day moving average of $28.28 and way below its 200-day moving average of $32.69.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Feb 5, 2023, the estimated forward annual dividend rate is 1.46 and the estimated forward annual dividend yield is 5.17%.
Previous days news about Intel
- : Intel cuts dividend by 66% in bid for ‘improved financial flexibility’. According to MarketWatch on Wednesday, 22 February, "The improved financial flexibility will support the critical investments needed to execute Intel’s transformation during this period of macroeconomic uncertainty." Intel reaffirmed its 2023 outlook, which calls for $10.5 billion to $11.5 billion in revenue and a 15-cent adjusted loss per share. "
More news about Intel.
10. Fortinet (FTNT) – Premarket: 1.66%
Fortinet, Inc. provides broad, integrated, and automated cybersecurity solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It offers FortiGate hardware and software licenses that provide various security and networking functions, including firewall, intrusion prevention, anti-malware, virtual private network, application control, web filtering, anti-spam, and wide area network acceleration. The company also provides FortiSwitch product family that offers secure switching solutions for connecting customers their end devices; FortiAP product family, which provides secure wireless networking solutions; FortiExtender, a hardware appliance; FortiAnalyzer product family, which offers centralized network logging, analyzing, and reporting solutions; and FortiManager product family that provides central and scalable management solution for its FortiGate products. It offers FortiWeb product family provides web application firewall solutions; FortiMail product family that secure email gateway solutions; FortiSandbox technology that delivers proactive detection and mitigation services; FortiClient that provides endpoint protection with pattern-based anti-malware, behavior-based exploit protection, web-filtering, and an application firewall; FortiToken and FortiAuthenticator product families for multi-factor authentication to safeguard systems, assets, and data; and FortiEDR/XDR, an endpoint protection solution that provides both comprehensive machine-learning anti-malware execution and real-time post-infection protection. It provides security subscription, technical support, professional, and training services. It sells its security solutions to channel partners and directly to various customers in telecommunications, technology, government, financial services, education, retail, manufacturing, and healthcare industries. It has strategic alliance with Linksys. Fortinet, Inc. was incorporated in 2000 and is headquartered in Sunnyvale, California.
NASDAQ ended the session with Fortinet rising 0.84% to $60.21 on Thursday while NASDAQ rose 0.13% to $11,507.07.
Earnings Per Share
As for profitability, Fortinet has a trailing twelve months EPS of $2.96.
PE Ratio
Fortinet has a trailing twelve months price to earnings ratio of 20.37. Meaning, the purchaser of the share is investing $20.37 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 289.24%.
Volume
Today’s last reported volume for Fortinet is 3936210 which is 26.79% below its average volume of 5377000.
Sales Growth
Fortinet’s sales growth is 25.7% for the current quarter and 23.6% for the next.
Moving Average
Fortinet’s worth is way above its 50-day moving average of $52.22 and way above its 200-day moving average of $53.78.
More news about Fortinet.
Premarket Losers Today
1. ImmunoGen (IMGN) – Premarket: -3.04%
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sunirine, a CD123-targeting ADC that is in Phase II clinical trial for treating acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm. Its preclinical programs include IMGC936, an ADC in co-development with MacroGenics, Inc.; and IMGN151, an anti FRa product candidate. The company has collaborations with Roche; Amgen/Oxford BioTherapeutics; Bayer HealthCare AG; Eli Lilly and Company; Novartis Institutes for BioMedical Research, Inc.; CytomX Therapeutics, Inc.; Fusion Pharmaceuticals Inc.; Debiopharm International SA; and MacroGenics, Inc. ImmunoGen, Inc. was founded in 1980 and is headquartered in Waltham, Massachusetts.
NASDAQ ended the session with ImmunoGen rising 0.13% to $3.95 on Thursday, following the last session’s upward trend. NASDAQ rose 0.13% to $11,507.07, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, ImmunoGen has a trailing twelve months EPS of $-0.252.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -157.66%.
Volatility
ImmunoGen’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.96%, a negative 0.86%, and a positive 2.82%.
ImmunoGen’s highest amplitude of average volatility was 3.10% (last week), 3.03% (last month), and 2.82% (last quarter).
Yearly Top and Bottom Value
ImmunoGen’s stock is valued at $3.95 at 07:34 EST, way under its 52-week high of $6.63 and way higher than its 52-week low of $3.10.
Revenue Growth
Year-on-year quarterly revenue growth grew by 66.9%, now sitting on 95.61M for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ImmunoGen’s stock is considered to be overbought (>=80).
More news about ImmunoGen.
2. Banco Bradesco (BBDO) – Premarket: -1.29%
Banco Bradesco S.A., together with its subsidiaries, provides various banking products and services to individuals, corporates, and businesses in Brazil and internationally. The company operates through two segments, Banking and Insurance. It provides current, savings, click, and salary accounts; real estate credit, vehicle financing, payroll loans, mortgage loans, microcredit, leasing, and personal and installment credit; debit and business cards; financial and security services; consortium products; auto, personal accident, dental, travel, and life insurance; investment products; pension products; real estate and vehicle auctions; cash management, and foreign trade and exchange services; capitalization bonds; and internet banking services. Banco Bradesco S.A. was founded in 1943 and is headquartered in Osasco, Brazil. Banco Bradesco S.A. is a subsidiary of Cidade de Deus – Companhia Comercial de Participações.
NYSE ended the session with Banco Bradesco falling 1.27% to $2.33 on Thursday while NYSE fell 0.27% to $15,530.83.
Earnings Per Share
As for profitability, Banco Bradesco has a trailing twelve months EPS of $0.299.
PE Ratio
Banco Bradesco has a trailing twelve months price to earnings ratio of 7.79. Meaning, the purchaser of the share is investing $7.79 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.02%.
More news about Banco Bradesco.
3. GlaxoSmithKline (GSK) – Premarket: -0.71%
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Wave Life Sciences Ltd.; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
NYSE ended the session with GlaxoSmithKline sliding 0.72% to $35.74 on Thursday while NYSE slid 0.27% to $15,530.83.
Earnings Per Share
As for profitability, GlaxoSmithKline has a trailing twelve months EPS of $2.88.
PE Ratio
GlaxoSmithKline has a trailing twelve months price to earnings ratio of 12.41. Meaning, the purchaser of the share is investing $12.41 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 31.31%.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Feb 22, 2023, the estimated forward annual dividend rate is 1.48 and the estimated forward annual dividend yield is 4.07%.
Moving Average
GlaxoSmithKline’s worth is above its 50-day moving average of $35.40 and below its 200-day moving average of $36.63.
Volume
Today’s last reported volume for GlaxoSmithKline is 1879290 which is 61.86% below its average volume of 4927790.
More news about GlaxoSmithKline.
4. Canopy Growth (CGC) – Premarket: -0.42%
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.
NASDAQ ended the session with Canopy Growth sliding 0.63% to $2.39 on Thursday while NASDAQ jumped 0.13% to $11,507.07.
Earnings Per Share
As for profitability, Canopy Growth has a trailing twelve months EPS of $-5.239.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -112%.
Volume
Today’s last reported volume for Canopy Growth is 8143690 which is 27.79% below its average volume of 11277800.
Revenue Growth
Year-on-year quarterly revenue growth declined by 28.2%, now sitting on 440.96M for the twelve trailing months.
Sales Growth
Canopy Growth’s sales growth for the current quarter is negative 18.9%.
Previous days news about Canopy Growth
- : canopy growth announces agreement with institutional investor to purchase up to $150 million of convertible bonds. According to MarketWatch on Tuesday, 21 February, "Canadian cannabis company Canopy Growth Corp. on Tuesday announced an agreement with an institutional investor to purchase up to $150 million of senior unsecured convertible bonds. ", "No cash will be payable by Canopy Growth in any circumstances in respect of principal, interest or any other amounts owing pursuant to the terms of the Convertible Debentures," the company said in a statement. "
More news about Canopy Growth.
5. United States Steel (X) – Premarket: -0.42%
United States Steel Corporation produces and sells flat-rolled and tubular steel products primarily in North America and Europe. It operates through four segments: North American Flat-Rolled (Flat-Rolled), Mini Mill, U. S. Steel Europe (USSE), and Tubular Products (Tubular). The Flat-Rolled segment offers slabs, strip mill plates, sheets, and tin mill products, as well as iron ore and coke. This segment serves customers in the service center, conversion, transportation, automotive, construction, container, appliance, and electrical markets. The Mini Mill segment provides hot-rolled, cold-rolled, and coated sheets and electrical products. This segment serves customers in the automotive, appliance, construction, container, transportation, and service center markets. The USSE segment provides slabs, strip mill plates, sheets, tin mill products, and spiral welded pipes. This segment serves customers in the construction, container, appliance and electrical, service center, conversion, oil, gas, and petrochemical markets. The Tubular segment offers seamless and electric resistance welded steel casing and tubing products, as well as standard and line pipe and mechanical tubing products primarily to customers in the oil, gas, and petrochemical markets. The company also engages in the real estate business. United States Steel Corporation was founded in 1901 and is headquartered in Pittsburgh, Pennsylvania.
NYSE ended the session with United States Steel jumping 0.18% to $28.39 on Thursday, after four consecutive sessions in a row of gains. NYSE dropped 0.27% to $15,530.83, after five sequential sessions in a row of losses, on what was a somewhat down trend trading session today.
Earnings Per Share
As for profitability, United States Steel has a trailing twelve months EPS of $-3.15.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 60.75%.
Yearly Top and Bottom Value
United States Steel’s stock is valued at $28.39 at 07:34 EST, way under its 52-week high of $39.25 and way above its 52-week low of $16.41.
More news about United States Steel.
6. Sabre Corporation (SABR) – Premarket: -0.39%
Sabre Corporation, through its subsidiary, Sabre Holdings Corporation, provides software and technology solutions for the travel industry worldwide. It operates in two segments, Travel Solutions and Hospitality Solutions. The Travel Solutions segment operates as a business-to-business travel marketplace that offers travel content, such as inventory, prices, and availability from a range of travel suppliers, including airlines, hotels, car rental brands, rail carriers, cruise lines, and tour operators with a network of travel buyers comprising online and offline travel agencies, travel management companies, and corporate travel departments. This segment also provides a portfolio of software technology products and solutions through software-as-a-service (SaaS) and hosted delivery models to airlines and other travel suppliers. Its products include reservation systems for carriers, commercial and operations products, agency solutions, and data-driven intelligence solutions. The Hospitality Solutions segment provides software and solutions to hoteliers through SaaS and hosted delivery models. Sabre Corporation was incorporated in 2006 and is headquartered in Southlake, Texas.
NASDAQ ended the session with Sabre Corporation falling 0.2% to $5.10 on Thursday while NASDAQ rose 0.13% to $11,507.07.
Earnings Per Share
As for profitability, Sabre Corporation has a trailing twelve months EPS of $-4.42.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Sabre Corporation’s stock is considered to be overbought (>=80).
Yearly Top and Bottom Value
Sabre Corporation’s stock is valued at $5.10 at 07:34 EST, way under its 52-week high of $11.89 and way above its 52-week low of $4.46.
Moving Average
Sabre Corporation’s worth is way under its 50-day moving average of $6.55 and way under its 200-day moving average of $6.42.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 36.2% and 58.6%, respectively.
More news about Sabre Corporation.
7. Horizon Therapeutics (HZNP) – Premarket: -0.35%
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines in the areas of rare diseases, gout, ophthalmology, and inflammation. It markets TEPEZZA (teprotumumab-trbw) for intravenous infusion; KRYSTEXXA (pegloticase injection) for intravenous infusion; RAVICTI (glycerol phenylbutyrate) oral liquid; PROCYSBI (cysteamine bitartrate) delayed-release capsules and granules for oral use; ACTIMMUNE (interferon gamma-1b) injection for subcutaneous use; BUPHENYL (sodium phenylbutyrate) tablets and powder for oral use; QUINSAIR (levofloxacin) solution for inhalation; and UPLIZNA (inebilizumab-cdon) injection for intravenous use. The company also markets PENNSAID (diclofenac sodium topical solution) for topical use; DUEXIS (ibuprofen/famotidine) tablets for oral use; RAYOS (prednisone) delayed-release tablets for oral use; and VIMOVO (naproxen/esomeprazole magnesium) delayed-release tablets for oral use. It has collaboration agreements with HemoShear Therapeutics, LLC.; Alpine Immune Sciences, Inc.; Halozyme Therapeutics, Inc.; Arrowhead Pharmaceuticals, Inc.; and Xeris Biopharma Holdings, Inc. The company was formerly known as Horizon Pharma Public Limited Company and changed its name to Horizon Therapeutics Public Limited Company in May 2019. Horizon Therapeutics Public Limited Company was founded in 2005 and is headquartered in Dublin, Ireland with additional offices in Deerfield, Illinois; Chicago, Illinois; Lake Forest, Illinois; South San Francisco, California; Washington, D.C.; Gaithersburg, Maryland; Rockville, Maryland; and Mannheim, Germany.
NASDAQ ended the session with Horizon Therapeutics rising 0.81% to $110.76 on Thursday while NASDAQ jumped 0.13% to $11,507.07.
Earnings Per Share
As for profitability, Horizon Therapeutics has a trailing twelve months EPS of $1.81.
PE Ratio
Horizon Therapeutics has a trailing twelve months price to earnings ratio of 61.2. Meaning, the purchaser of the share is investing $61.2 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.11%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is a negative 22.7% and a negative 17.9%, respectively.
Revenue Growth
Year-on-year quarterly revenue growth declined by 10.8%, now sitting on 3.7B for the twelve trailing months.
More news about Horizon Therapeutics.
8. U.S. Gold Corp (USAU) – Premarket: -0.24%
U.S. Gold Corp. engages in the exploration and development of gold and precious metals in the United States. It also explores for copper and silver deposits. The company holds 100% interests in the CK Gold project, which consists of various mining leases and other mineral rights covering approximately 1,120 acres in Laramie County, Wyoming; the Keystone project that consists of 650 unpatented lode mining claims covering approximately 20 square miles in Eureka County, Nevada; and the Challis Gold project, which consists of 87 unpatented lode mining claims covering approximately 1,710 acres in Lemhi County, Idaho. It also has earn-in agreement to acquire a 50% ownership interest in the Maggie Creek project that consists of 103 unpatented mining claims covering approximately 3 square miles in Eureka County, Nevada. The company is based in Elko, Nevada.
NASDAQ ended the session with U.S. Gold Corp dropping 0.95% to $4.15 on Thursday while NASDAQ jumped 0.13% to $11,507.07.
Earnings Per Share
As for profitability, U.S. Gold Corp has a trailing twelve months EPS of $-4.367.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -45.57%.
Moving Average
U.S. Gold Corp’s value is way under its 50-day moving average of $4.64 and below its 200-day moving average of $4.24.
More news about U.S. Gold Corp.
9. Sempra Energy (SRE) – Premarket: -0.1%
Sempra operates as an energy-services holding company in the United States and internationally. The company's San Diego Gas & Electric Company segment provides electric services; and supplies natural gas. It offers electric services to approximately 3.6 million population and natural gas services to approximately 3.3 million population that covers 4,100 square miles. Its Southern California Gas Company segment owns and operates a natural gas distribution, transmission, and storage system that supplies natural gas to a population of approximately 22 million covering an area of 24,000 square miles. The company's Sempra Texas Utilities segment engages in the regulated transmission and distribution of electricity serving 3.8 million homes and businesses, and operation of 140,000 miles of transmission and distribution lines. Its transmission system includes 18,249 circuit miles of transmission lines, a total of 1,174 transmission and distribution substations, and interconnection to 130 third-party generation facilities totaling 45,403 megawatts. The company was formerly known as Sempra Energy and changed its name to Sempra in July 2021. Sempra was founded in 1998 and is headquartered in San Diego, California.
NYSE ended the session with Sempra Energy dropping 0.17% to $155.16 on Thursday, after four consecutive sessions in a row of losses. NYSE dropped 0.27% to $15,530.83, after five sequential sessions in a row of losses, on what was a somewhat down trend trading session today.
Earnings Per Share
As for profitability, Sempra Energy has a trailing twelve months EPS of $12.88.
PE Ratio
Sempra Energy has a trailing twelve months price to earnings ratio of 12.05. Meaning, the purchaser of the share is investing $12.05 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.6%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is a negative 5.6% and a negative 7.6%, respectively.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Dec 20, 2022, the estimated forward annual dividend rate is 4.58 and the estimated forward annual dividend yield is 2.97%.
Volume
Today’s last reported volume for Sempra Energy is 576280 which is 50% below its average volume of 1152740.
Sales Growth
Sempra Energy’s sales growth is negative 1.5% for the ongoing quarter and negative 1.1% for the next.
More news about Sempra Energy.
10. Rollins (ROL) – Premarket: -0.03%
Rollins, Inc., through its subsidiaries, provides pest and wildlife control services to residential and commercial customers in the United States and internationally. The company offers pest control services to residential properties protecting from common pests, including rodents, insects, and wildlife. It also provides workplace pest control solutions for customers across various end markets, such as healthcare, foodservice, and logistics. In addition, the company offers traditional and baiting termite protection, as well as ancillary services. It serves clients directly, as well as through franchisee operations. Rollins, Inc. was incorporated in 1948 and is headquartered in Atlanta, Georgia.
NYSE ended the session with Rollins jumping 0.13% to $35.42 on Thursday, after two sequential sessions in a row of gains. NYSE fell 0.27% to $15,530.83, after five consecutive sessions in a row of losses, on what was a somewhat negative trend exchanging session today.
Earnings Per Share
As for profitability, Rollins has a trailing twelve months EPS of $0.63.
PE Ratio
Rollins has a trailing twelve months price to earnings ratio of 56.23. Meaning, the purchaser of the share is investing $56.23 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 30.09%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 12.2%, now sitting on 2.63B for the twelve trailing months.
Yearly Top and Bottom Value
Rollins’s stock is valued at $35.42 at 07:34 EST, way under its 52-week high of $43.06 and way above its 52-week low of $29.82.
More news about Rollins.
Stay up to date with our premarket winners and losers daily report
